Management of patients with multiple myeloma in the era of COVID-19 pandemic: how hospital at home changes our medical practice
Ce dossier présente un ensemble d'articles concernant la prise en charge des cancers durant la crise sanitaire liée au COVID-19
Oncology and hematology physicians aim during the COVID-19 pandemic to protect their patients from COVID-19 infection without impairing the prognosis of the disease. Consensus recommendations have thus been implemented for the management of cancer patients during this period [1]. Karacin et al. reported on the reorganization of oncology hospitals in Ankara [2] and described the increased use of telemedicine, admission procedures in “clean” and “pandemic” centers, and preventive strategies.
Patients with hematological diseases, especially multiple myeloma (MM), are at high risk of infection as they are often older than 65 years, and are highly immunosuppressed due to their treatments and the disease itself [2]. The management of patients with multiple myeloma is therefore a specific challenge in the context of COVID-19 [3].
Supportive Care in Cancer , éditorial, 2021